BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7737689)

  • 41. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
    Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
    Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
    Moldenhauer G; Henne C; Karhausen J; Möller P
    Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
    J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
    Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal.
    Anderson MS; Swier K; Arneson L; Miller J
    J Exp Med; 1993 Dec; 178(6):1959-69. PubMed ID: 7902408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments.
    Castellino F; Germain RN
    Immunity; 1995 Jan; 2(1):73-88. PubMed ID: 7600303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invariant chain increases the half-life of MHC II by delaying endosomal maturation.
    Landsverk OJ; Barois N; Gregers TF; Bakke O
    Immunol Cell Biol; 2011 Jul; 89(5):619-29. PubMed ID: 21116285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
    Germain RN
    Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.
    Martin WD; Hicks GG; Mendiratta SK; Leva HI; Ruley HE; Van Kaer L
    Cell; 1996 Feb; 84(4):543-50. PubMed ID: 8598041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathways of antigen processing.
    Blum JS; Wearsch PA; Cresswell P
    Annu Rev Immunol; 2013; 31():443-73. PubMed ID: 23298205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Hsing LC; Rudensky AY
    Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
    van Niel G; Wubbolts R; Stoorvogel W
    Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endosomal compartment: Also a dock for MHC class I peptide loading.
    Ma W; Van den Eynde BJ
    Eur J Immunol; 2014 Mar; 44(3):650-3. PubMed ID: 24515851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
    J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.